Anacor Shares Surge To All-Time Highs After Phase 3 Trials Of Eczema Drug
July 13, 2015 at 15:29 PM EDT
In a public conference call on Monday, Anacor Pharmaceuticals Inc (NASDAQ: ANAC) executives announced the results of two Phase 3 trials ...